Priced by method, not by term
The protocol table looks at first like a term ladder — its header row offers a monthly, a three-month and a six-month tab — and then prints two figures under semaglutide, three under tirzepatide, two under one longevity product and one under another.
Those counts do not match three tabs. They match the entries in each product's own choose-a-method list: semaglutide offers a microdose injection and a standard injection, tirzepatide adds liposomal tablets, and the counts line up exactly. So the figures are per method.
We have recorded them that way, one row per method, and written into every qualifier that the term the figures belong to is not established on the page as served. That is a real limit and pretending otherwise would put a monthly label on a number that might be a six-month rate.
A tablet at the price of an injection
The tirzepatide liposomal tablet is priced identically to the tirzepatide standard injection. Twenty-seven of the one hundred and fifty-eight sellers here price an oral route at all, and most charge a premium for it.
Pricing the microdose lower than the standard dose is the other useful thing here. A seller that quotes one starting figure across both is quoting the microdose and selling the standard, and several on this roster do exactly that.
Nothing is billed until it is prescribed
The page states twice that a patient is only billed if a licensed physician approves the prescription, and that a patient who does not qualify owes nothing. It also states that every price includes physician review, supplies and free shipping, and that compounding and ongoing care are bundled into a single monthly price.
We have recorded the membership as included on that basis. Fourteen of the one hundred and fifty-eight sellers here publish a figure that already covers everything.
The site links a pharmacy-standards page and a team page from its own navigation, but names no compounding pharmacy and no clinician in the pages we read. No service area is published.
Whoosh Wellness's published pricing
| Medication | Price | Verified |
|---|---|---|
| Semaglutide (compounded) | $149/mostarting at, per month, for the microdose injection method; the protocol table offers Monthly, 3-Month and 6-Month tabs and prints one figure per delivery method rather than per term | September 2026source |
| Semaglutide (compounded) | $169/mostarting at, per month, for the standard injection method | September 2026source |
| Tirzepatide (compounded) | $199/mostarting at, per month, for the microdose injection method | September 2026source |
| Tirzepatide (compounded) | $249/mostarting at, per month, for the standard injection method | September 2026source |
| Tirzepatide (compounded-oral) | $249/mostarting at, per month, for the liposomal tablet method, priced identically to the standard injection | September 2026source |
compareglp may earn a commission when a reader signs up with a provider through a link on this site. 4 of the 158 providers reviewed here are paid partners today; the other 154 are not. See how this works.
See Whoosh Wellness's current price →Good fit if
- Buyers choosing between a microdose, a standard injection and a tablet who want all three priced.
- Readers who want a written promise that nothing is billed before a prescription is approved.
- People who want to see an oral route priced at the same rate as an injection.
Look elsewhere if
- Anyone who needs to know which commitment length a printed figure belongs to. The table offers three tabs and the page as served does not distinguish them.
- Readers who want the compounding pharmacy or a clinician named.
- Buyers who need a service-area list.
How this review was verified
- Re-read the pricing page and the HIPAA privacy policy on 6 September 2026, comparing the requested path to the effective path and running a nonsense path against the host in the same run.
- Matched the count of printed figures against the count of delivery methods for all five protocols on the page before concluding that the figures are per method rather than per term. Two, three, two and one, in each case matching the method list exactly.
- Wrote the unresolved term question into every price qualifier rather than assuming the monthly tab.
- Set the membership status from two separate statements on the page about what the single price includes.
- Screened the operating entity and the brand name against FDA's live warning-letter record with a known letter as a positive control and a nonsense string as a negative control in the same pass. Neither returned a letter. Untitled letters are published separately and were not searched.